Just four weeks ago, Rwanda had no history of Marburg virus disease. Today, the nation is confronting its first outbreak, with 58 confirmed infections and 13 fatalities, concentrated heavily in the capital, Kigali.
The World Health Organization was notified on September 28, triggering an urgent response against a pathogen with an average fatality rate of 50 percent. Confirmed cases have emerged in seven of Rwanda’s 30 districts, but three districts within Kigali report the highest numbers. This geographic concentration poses a significant challenge.
As the country’s population hub, economic center, and international transit point, an outbreak in Kigali is far more difficult to control than one in a remote area. A striking feature of this outbreak is that most confirmed cases are healthcare workers, particularly those in intensive care units.
This cruel irony means the individuals trained to save lives face the greatest exposure. Marburg virus, a filovirus in the same family as Ebola, causes hemorrhagic fever and spreads through direct contact with bodily fluids. No approved vaccine or specific antiviral treatment exists; only supportive care is available. For healthcare workers, every procedure—from intubation to inserting an IV line—carries the risk that protective equipment may fail.
The high number of infected medical staff suggests a breach in infection control protocols. Rwanda’s health system has earned praise for its resilience, rebuilt after the 1994 genocide and strengthened by ambitious universal health coverage.
The country managed COVID-19 more effectively than many wealthier nations. However, Marburg presents a distinct challenge. First identified in 1967 among laboratory workers in Marburg, Germany, who handled African green monkeys from Uganda, the virus has caused sporadic outbreaks.
Angola experienced a major epidemic in 2004-2005 with 252 cases and 227 deaths. Ghana reported its first outbreak in 2022, and Uganda has faced multiple episodes.
Rwanda had remained untouched until now. The source of the current outbreak remains unknown. Fruit bats of the species Rousettus aegyptiacus are considered the natural reservoir, and past infections have occurred among miners and tourists entering caves where these bats roost.
However, how the virus entered Rwanda is not specified in available information. This outbreak is already the second-largest recorded in Africa since the Angola epidemic.
The current figures—58 cases and 13 deaths—are preliminary and expected to rise. The WHO is assisting local health authorities with contact tracing and establishing isolation units. Yet each day without identifying the outbreak’s source increases the risk of undetected spread beyond known cases.
For the healthcare workers who constitute the majority of patients, the stakes are deeply personal. They understand the disease’s progression, including bleeding from the eyes, nose, and gums.
They know their deceased colleagues stood where they now stand. Rwanda has overcome severe challenges before, but never this specific threat. The coming weeks will determine whether this outbreak becomes a contained incident or a larger catastrophe.
